Accretion Nutraveda IPO : GMP, Price, Analysis, And Details

Accretion Nutraveda IPO- Company Analysis 

Accretion Nutraveda IPO under the SME IPO category is a bookbuild issue of Rs. 24.77 Cr by Accretion Nutraveda Limited and producing numerous dosage forms of Ayurvedic and nutraceutical products in diverse forms such as tablets, capsules, oral liquid, powder, oil or topical preparation such as a gel, brahmo or cream.

Verticals of business

• Direct Exports  
• Domestic Sales & Merchant Exports (Loan License Basis)
  
  

Accretion Nutraveda IPO Details

The Accretion Nutraveda IPO date of opening is 28 Jan 2026, its initial public offering will end on 30 Jan, IPO allotment on Feb 02 and refund initiation on Feb 03, 2026.

The Rs. 24.77 crore new SME IPO comprises a wholly fresh issue of 0.19 crore shares.

The Accretion Nutraveda IPO listing date (expected) might be on Wednesday, Feb 04, 2026, and listing at the BSE and SME. 

The Accretion Nutraveda IPO price band is Rs. 122 to Rs. 129.

 

 

IPO Timetable (Tentative)

Events	Date
IPO Opening Date	Jan 28, 2026
IPO Closing Date	Jan 30, 2026
IPO Allotment Date	Feb 02, 2026
Refund Initiation	Feb 03, 2026
IPO Listing Date	Feb 04, 2026

 

Click to open demat account and apply for the IPO.

Company Financials 

(Amount in Cr)

Particulars	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	10.86	4.64	4.06
Total Income	16.06	5.20	3.07
PAT	2.61	0.82	0.28
EBITDA	3.65	1.21	0.59
Net Worth	5.35	1.08	0.26
Reserves & Surplus	4.86	0.72	-0.10
Total Borrowing	3.86	2.17	1.97

 

Cash Flows

(Amount in lac)

Net Cash Flow	31 Mar 2025	31 Mar 2024	31 Mar 2023
Net Cash Flow Operating Activities	-221.27	23.02	68.13
Net Cash Flow Investing Activities	-87.20	-15.83	-0.55
Net Cash Flow Financing Activities	298.12	-3.91	-63.40

 

Revenue Bifurcation

(Rs. in Lac)

(Source: RHP)

The Objective of the Issue

The company desires to use the Net Proceeds from the Issue to fulfill its following goals:

• Purchase of machinery for Automation in the existing Manufacturing unit. ~ Rs. 4.22 Cr.
• Purchase of machinery for the new manufacturing setup. ~ Rs. 8.03 Cr.
• Funding the working capital requirements of our company. ~ Rs. 5.50 Cr.
• General Corporate Purpose.
  
  

Listed Peers of Accretion Nutraveda Ltd. 

Name of Company	Face Value (₹)	Basic EPS (₹)	PE Ratio (x)
Walpar Nutritions Ltd.	10	1.06	3.30
Influx Healthtech Ltd.	10	4.81	46.99

 

Valuation

KPI	Value
ROE	81.22%
ROCE	36.98%
Debt / Equity	0.72
RoNW	48.85%
PAT Margin	16.33%
EBITDA Margin	22.79%
Price to Book Value	8.76

 

Evaluation of P/E Ratio

Considering the period ended on FY 2025 with an EPS of Rs. 7.19 from the last year, the resulting P/E ratio is 17.94x.

Explore the Bai Kakaji Polymers IPO.

IPO's Strengths 

• Promoters and a management team with experience.
• A wide range of products.
• Dedication to high standards of excellence.
• Connections with suppliers and customers.
• Established structure for management and business processes.

 

 

IPO’s Weaknesses

• Excessive dependence on a certain geographic market, which restricts prospects for expansion.
• The cycle of intensive working capital.
• High capital expenditure requirements.
  
  

Accretion Nutraveda IPO GMP (Grey Market Premium)

Accretion Nutraveda IPO GMP today is Rs. 0 as of 22 Jan 2026 while writing this information. With a price band set at Rs. 129, the estimated listing price of the IPO could be around Rs. 129, indicating a gain/loss of 0%.

Accretion Nutraveda IPO Summary

IPO Opening & Closing Date	28 Jan, 2026 to 30 Jan, 2026
Face Value	Rs. 10 per Share
Issue Price	Rs. 122 to Rs. 129 per Share.
Lot Size	1000 Shares
Issue Size	19,20,000 Shares (Rs. 25 Cr)
Offer for Sale	-
Fresh Issue	19,20,000 Shares (Rs. 25 Cr)
Listing at	BSE, SME
Issue Type	Bookbuild issue IPO
Registrar	Kfin Technologies Ltd.

 

IPO Lot Details 

Retail investors can invest in a minimum of 2 Lots (2000 Shares) for Rs. 2,58,000, and in multiples thereof, while HNI investors can invest in a minimum of 3 Lots (3000 Shares) for Rs. 3,87,000.

Minimum Lot Investment (Retail)	2 Lots
Maximum Lot Investment (Retail)	2 Lots
HNI (Min)	3 Lots

 

Accretion Nutraveda IPO Allotment Status

To check the Accretion Nutraveda IPO Allotment Status, visit the official Registrar’s website or BSE website. Below are the website links for you.

Using BSE Website - ​BSE IPO allotment status

Promoters And Management of Accretion Nutraveda Ltd.

• Mr. Mayur Popatlal Sojitra
• Mr. Ankurkumar Shantilal Patel
• Mr. Paraskumar Vinubhai Parmar
• Mr. Hardik Mukundbhai Prajapati
• Mr. Harshad Nanubhai Rathod 
• Mr. Vivek Ashok Kumar Patel.
  
  

Pre-Issue Promoter Shareholding	100%
Post-Issue Promoter Shareholding	73.48%

 

IPO Lead Managers

• Sobhagya Capital Options Pvt. Ltd.
  
  

Dividend Policy

The company has not paid a dividend during the last three years.

 

 

Conclusion

With outstanding FY25 profitability and good return ratios, Accretion Nutraveda Limited's IPO offers a unique CDMO position in the rapidly expanding Ayurvedic and nutraceutical market. Working-capital intensity and zero GMP indicate cautious optimism, even though values seem acceptable and growth visibility is supported by capacity expansion.

Instead of focusing on short-term listing gains, risk-conscious SME investors may monitor this IPO for long-term prospects.

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

To Read the Prospectus of the Company Click Here to Download the DRHP.

Click Here To Stay Updated With The Upcoming IPOs.

DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.